◂ Last issue Next issue ▸ Archive Cover PDF   

Volume 9 (3); 2018

Research Papers

The Unknown microRNA Expression of Male Breast Cancer. Similarities and Differences with Female Ductal Carcinoma. Their Role as Tumor Biomarker
Maria J Merino, Sara Gil, Carmen Garcia Macias, Karlena Lara
J. Cancer 2018; 9(3): 450-459. doi:10.7150/jca.23151
Full text PDF PubMed PMC

MK2 and ETV1 Are Prognostic Factors in Esophageal Adenocarcinomas
Gerd Jomrich, Florian Maroske, Jasmin Stieger, Matthias Preusser, Aysegül Ilhan-Mutlu, Daniel Winkler, Ivan Kristo, Matthias Paireder, Sebastian Friedrich Schoppmann
J. Cancer 2018; 9(3): 460-468. doi:10.7150/jca.22310
Full text PDF PubMed PMC

Exploration of Racial Differences in Reproductive Factors for Breast Cancer among Women aged 55-74
Chuanbo Xie, Nan Shao, Longjun He, Xiuhong Li, Cong Li, Jibin Li, Dongfang Su
J. Cancer 2018; 9(3): 469-478. doi:10.7150/jca.22869
Full text PDF PubMed PMC

Clinicopathological Characteristics of the primary and metastatic Hepatic Neuroendocrine Tumors and the relevant Prognosis-Related Factors: A Retrospective Study of 81 Cases in a Single Chinese Center
Yang Lv, Cheng Huang, Haizhou Xu, Xu Han, Lei Zhang, Weilin Mao, Yuan Ji, Dayong Jin, Wenhui Lou, Xuefeng Xu
J. Cancer 2018; 9(3): 479-487. doi:10.7150/jca.22157
Full text PDF PubMed PMC

Influence of diabetes on the risk of urothelial cancer according to body mass index: a 10-year nationwide population-based observational study
Woong Jin Bae, Jin Bong Choi, Hyong Woo Moon, Young Hyun Park, Hyuk Jin Cho, Sung-Hoo Hong, Ji Youl Lee, Sae Woong Kim, Kyung-Do Han, U-Syn Ha
J. Cancer 2018; 9(3): 488-493. doi:10.7150/jca.22107
Full text PDF PubMed PMC

Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients
Shufang Ning, Wene Wei, Jilin Li, Bingbing Hou, Jianhong Zhong, Yuxuan Xie, Haizhou Liu, Xianwei Mo, Jiansi Chen, Litu Zhang
J. Cancer 2018; 9(3): 494-501. doi:10.7150/jca.21562
Full text PDF PubMed PMC

Recombinant nanocomposites by the clinical drugs of Abraxane^® and Herceptin^® as sequentially dual-targeting therapeutics for breast cancer
Shuang Ding, Jian Xiong, Dan Lei, Xiao-li Zhu, Hai-jun Zhang
J. Cancer 2018; 9(3): 502-511. doi:10.7150/jca.22163
Full text PDF PubMed PMC

Elevated baseline serum lactate dehydrogenase indicates a poor prognosis in primary duodenum adenocarcinoma patients
Zhan-hong Chen, Miao-zhen Qiu, Xiang-yuan Wu, Qi-nian Wu, Jia-huan Lu, Zhao-lei Zeng, Yun Wang, Xiao-li Wei, Feng Wang, Rui-hua Xu
J. Cancer 2018; 9(3): 512-520. doi:10.7150/jca.22305
Full text PDF PubMed PMC

Impact of Weight Loss at Presentation on Survival in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) Sensitive Mutant Advanced Non-small Cell Lung Cancer (NSCLC) Treated with First-line EGFR-TKI
Liping Lin, Juanjuan Zhao, Jiazhu Hu, Fuxi Huang, Jianjun Han, Yan He, Xiaolong Cao
J. Cancer 2018; 9(3): 528-534. doi:10.7150/jca.22378
Full text PDF PubMed PMC

Association between NEFL Gene Polymorphisms and Neuroblastoma Risk in Chinese Children: A Two-Center Case-Control Study
Qiang Wu, Zhen-Jian Zhuo, Jixiao Zeng, Jiao Zhang, Jinhong Zhu, Yan Zou, Ruizhong Zhang, Tianyou Yang, Deli Zhu, Jing He, Huimin Xia
J. Cancer 2018; 9(3): 535-539. doi:10.7150/jca.22681
Full text PDF PubMed PMC

Identification of Kininogen 1 as a Serum Protein Marker of Colorectal Adenoma in Patients with a Family History of Colorectal Cancer
Jiekai Yu, Yanqin Huang, Chen Lin, Xiaofen Li, Xuefeng Fang, Chenhan Zhong, Ying Yuan, Shu Zheng
J. Cancer 2018; 9(3): 540-547. doi:10.7150/jca.22405
Full text PDF PubMed PMC

Clinical study on the prevalence and comparative analysis of metabolic syndrome and its components among Chinese breast cancer women and control population
Yu-tuan Wu, Qing-qing Luo, Xin Li, Bilal Arshad, Zhou Xu, Liang Ran, Chun-xia Zhao, He Wu, Yan-ling Shi, Hao-ran Chen, Hao Li, Hong-yuan Li, Kai-nan Wu, Ling-quan Kong
J. Cancer 2018; 9(3): 548-555. doi:10.7150/jca.22968
Full text PDF PubMed PMC

The prognostic value of Niemann-Pick C1-like protein 1 and Niemann-Pick disease type C2 in hepatocellular carcinoma
Ke-Ji Chen, Ri-Ming Jin, Chun-Chao Shi, Rui-Liang Ge, Lei Hu, Qi-Fei Zou, Quan-Yu Cai, Guang-Zhi Jin, Kui Wang
J. Cancer 2018; 9(3): 556-563. doi:10.7150/jca.19996
Full text PDF PubMed PMC

Folic acid-modified diatrizoic acid-linked dendrimer-entrapped gold nanoparticles enable targeted CT imaging of human cervical cancer
Jiaying Lin, Weiwei Hu, Fengli Gao, Jinbao Qin, Chen Peng, Xinwu Lu
J. Cancer 2018; 9(3): 564-577. doi:10.7150/jca.19786
Full text PDF PubMed PMC

Down-expression of CD36 in pancreatic adenocarcinoma and its correlation with clinicopathological features and prognosis
Shengnan Jia, Liangjing Zhou, Tao Shen, Senhao Zhou, Guoping Ding, Liping Cao
J. Cancer 2018; 9(3): 578-583. doi:10.7150/jca.21046
Full text PDF PubMed PMC

Role of Postoperative Concurrent Chemoradiotherapy for Esophageal Carcinoma: A meta-analysis of 2165 Patients
Jingjing Kang, Joe Y. Chang, Xin Sun, Yu Men, Hongmei Zeng, Zhouguang Hui
J. Cancer 2018; 9(3): 584-593. doi:10.7150/jca.20940
Full text PDF PubMed PMC

Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis
Fangzheng Wang, Quanquan Sun, Chuner Jiang, Tongxin Liu, Aizawa Rihito, Sakamoto Masoto, Yuezhen Wang, Zhenfu Fu, Ming Chen
J. Cancer 2018; 9(3): 594-603. doi:10.7150/jca.20461
Full text PDF PubMed PMC

Differential expression and clinical significance of epithelial-mesenchymal transition markers among different histological types of triple-negative breast cancer
Shuling Zhou, Xiangjie Sun, Lin Yu, Ruoji Zhou, Anqi Li, Ming Li, Wentao Yang
J. Cancer 2018; 9(3): 604-613. doi:10.7150/jca.19190
Full text PDF PubMed PMC

The role of cancer-associated fibroblast MRC-5 in pancreatic cancer
Song-Ming Ding, Ai-Li Lu, Wu Zhang, Lin Zhou, Hai-Yang Xie, Shu-Sen Zheng, Qi-Yong Li
J. Cancer 2018; 9(3): 614-628. doi:10.7150/jca.19614
Full text PDF PubMed PMC

Review

Overexpression of MICAL2, a novel tumor-promoting factor, accelerates tumor progression through regulating cell proliferation and EMT
Yongqiang Cai, Jinping Lu, Faqing Tang
J. Cancer 2018; 9(3): 521-527. doi:10.7150/jca.22355
Full text PDF PubMed PMC

©2024 Ivyspring International Publisher. Terms of use